Mammalian target of rapamycin (mTOR) signaling has recently emerged as a key effector molecule in Syk activation (25) which seems to be particularly important for inhibiting FOXP3 transcription (26) and has been implicated in RA (27). This evidence concerns the gene SYK and rheumatoid arthritis.